References
-
1.
Hajarizadeh B, Razavi-Shearer D, Merat S, Alavian SM, Malekzadeh R, Razavi H. Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden. Hepat Mon. 2016;16(7). e37234. [PubMed ID: 27642346]. https://doi.org/10.5812/hepatmon.37234.
-
2.
Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, et al. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepat Mon. 2016;16(8). e40959. [PubMed ID: 27799966]. https://doi.org/10.5812/hepatmon.guideline.
-
3.
Younus I, Sarwar S, Qaadir A, Butt Z, Nazir A, Choudry A. Correlation of literacy and awareness regarding hepatitis C: a survey of family members of hepatitis C patients. Int J Med Res Rev. 2016;4(9).
-
4.
Saffar H, Ajami A, Saffar MJ, Shojaei J, Sotudeh-Anvari M, Shams-Esfandabad K, et al. Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in iran. Hepat Mon. 2014;14(5). e17263. [PubMed ID: 24829589]. https://doi.org/10.5812/hepatmon.17263.
-
5.
Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon. 2016;16(4). e35577. [PubMed ID: 27257428]. https://doi.org/10.5812/hepatmon.35577.
-
6.
Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, et al. Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran. Hepat Mon. 2016;16(9). e36452. [PubMed ID: 27822260]. https://doi.org/10.5812/hepatmon.36452.
-
7.
Roushan N, Nasiri Toosi M, Meysamie A, Esteghamati AR, Hajrassuliha H. Hepatitis B knowledge among Iranian adolescents: a national survey. Iran Red Crescent Med J. 2013;15(12). e11558. [PubMed ID: 24693383]. https://doi.org/10.5812/ircmj.11558.
-
8.
Karimi-Sari H, Tajik M, Bayatpoor ME, Alavian SM. Increasing the Awareness of the General Population: An Important Step in Elimination Programs of Viral Hepatitis. Am J Gastroenterol. 2017;112(2):393-5. [PubMed ID: 28154404]. https://doi.org/10.1038/ajg.2016.534.
-
9.
Towards elimination of viral hepatitis by 2030. Lancet. 2016;388(10042):308. [PubMed ID: 27477148]. https://doi.org/10.1016/S0140-6736(16)31144-8.
-
10.
Ebrahimzadeh A, Azarkar Z, Ziaee M, Sharifzadeh G, Bijari B. Prevalence and risk factors of hepatitis C infection (HCV) in Birjand, Iran, 2014. Int J Infect. 2016;3(1). https://doi.org/10.17795/iji-34102.
-
11.
Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepat Mon. 2016;16(4). e37089. [PubMed ID: 27275164]. https://doi.org/10.5812/hepatmon.37089.